Form 8-K - Current report:
SEC Accession No. 0001628280-20-006158
Filing Date
2020-05-01
Accepted
2020-05-01 17:16:59
Documents
2
Period of Report
2020-05-01
Items
Item 4.01: Changes in Registrant's Certifying Accountant
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K a8-kchangeofauditors5x1x20.htm 8-K 38565
2 EXHIBIT 16.1 lettertothesecuritiesandex.htm EX-16.1 3830
  Complete submission text file 0001628280-20-006158.txt   43510
Mailing Address 2525 WEST END AVENUE SUITE 950 NASHVILLE TN 37203
Business Address 2525 WEST END AVENUE SUITE 950 NASHVILLE, TN 37203 615-255-0068
CUMBERLAND PHARMACEUTICALS INC (Filer) CIK: 0001087294 (see all company filings)

EIN.: 000000000 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-33637 | Film No.: 20841866
SIC: 2834 Pharmaceutical Preparations